Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Mycoplasma Clearance and Risk Analysis in a Model Bioprocess: Robustness with Respect to Mycoplasma Species.

Faison T, Wang J, Johnson S, Brown M, Chiang MJ, Dolan S, Breuning C, Velugula-Yellela SR, Lute S, Fratz-Berilla EJ, Brorson K.

PDA J Pharm Sci Technol. 2019 Sep 13. pii: pdajpst.2018.009613. doi: 10.5731/pdajpst.2018.009613. [Epub ahead of print]

PMID:
31519782
2.

Impacts of intentional mycoplasma contamination on CHO cell bioreactor cultures.

Fratz-Berilla EJ, Faison T, Kohnhorst CL, Velugula-Yellela SR, Powers DN, Brorson K, Agarabi C.

Biotechnol Bioeng. 2019 Dec;116(12):3242-3252. doi: 10.1002/bit.27161. Epub 2019 Sep 11.

3.

Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System.

Velugula-Yellela SR, Powers DN, Angart P, Faustino A, Faison T, Kohnhorst C, Fratz-Berilla EJ, Agarabi CD.

J Vis Exp. 2019 May 1;(147). doi: 10.3791/58947.

PMID:
31107445
4.

Use of High-Throughput Automated Microbioreactor System for Production of Model IgG1 in CHO Cells.

Velugula-Yellela SR, Kohnhorst C, Powers DN, Trunfio N, Faustino A, Angart P, Berilla E, Faison T, Agarabi C.

J Vis Exp. 2018 Sep 28;(139). doi: 10.3791/58231.

5.

Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma.

Rieken M, Xylinas E, Kluth L, Crivelli JJ, Chrystal J, Faison T, Lotan Y, Karakiewicz PI, Sun M, Fajkovic H, Babjuk M, Bachmann A, Scherr DS, Shariat SF.

Urol Oncol. 2014 Jan;32(1):49.e7-14. doi: 10.1016/j.urolonc.2013.07.006. Epub 2013 Oct 17.

PMID:
24140245
6.

Association of diabetes mellitus and metformin use with biochemical recurrence in patients treated with radical prostatectomy for prostate cancer.

Rieken M, Kluth LA, Xylinas E, Fajkovic H, Becker A, Karakiewicz PI, Herman M, Lotan Y, Seitz C, Schramek P, Remzi M, Loidl W, Pummer K, Lee RK, Faison T, Scherr DS, Kautzky-Willer A, Bachmann A, Tewari A, Shariat SF.

World J Urol. 2014 Aug;32(4):999-1005. doi: 10.1007/s00345-013-1171-7. Epub 2013 Sep 24.

PMID:
24062093
7.

Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancer.

Rieken M, Xylinas E, Kluth L, Crivelli JJ, Chrystal J, Faison T, Lotan Y, Karakiewicz PI, Fajkovic H, Babjuk M, Kautzky-Willer A, Bachmann A, Scherr DS, Shariat SF.

BJU Int. 2013 Dec;112(8):1105-12. doi: 10.1111/bju.12448.

8.

Impact of statin use on biochemical recurrence in patients treated with radical prostatectomy.

Rieken M, Kluth LA, Xylinas E, Seitz C, Fajkovic H, Karakiewicz PI, Lotan Y, Briganti A, Loidl W, Faison T, Crivelli JJ, Scherr DS, Bachmann A, Tewari AK, Kautzky-Willer A, Pummer K, Shariat SF.

Prostate Cancer Prostatic Dis. 2013 Dec;16(4):367-71. doi: 10.1038/pcan.2013.31. Epub 2013 Sep 3.

PMID:
23999669
9.

Long-term cancer-specific outcomes of TaG1 urothelial carcinoma of the bladder.

Rieken M, Xylinas E, Kluth L, Crivelli JJ, Chrystal J, Faison T, Lotan Y, Karakiewicz PI, Holmäng S, Babjuk M, Fajkovic H, Seitz C, Klatte T, Pycha A, Bachmann A, Scherr DS, Shariat SF.

Eur Urol. 2014 Jan;65(1):201-9. doi: 10.1016/j.eururo.2013.08.034. Epub 2013 Aug 27.

PMID:
23998688
10.

Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy.

Xylinas E, Rink M, Robinson BD, Lotan Y, Babjuk M, Brisuda A, Green DA, Kluth LA, Pycha A, Fradet Y, Faison T, Lee RK, Karakiewicz PI, Zerbib M, Scherr DS, Shariat SF.

Eur J Cancer. 2013 May;49(8):1889-97. doi: 10.1016/j.ejca.2013.02.001. Epub 2013 Mar 4.

PMID:
23466126
11.

Prediction of true nodal status in patients with pathological lymph node negative upper tract urothelial carcinoma at radical nephroureterectomy.

Xylinas E, Rink M, Margulis V, Faison T, Comploj E, Novara G, Raman JD, Lotan Y, Guillonneau B, Weizer A, Pycha A, Scherr DS, Seitz C, Sun M, Trinh QD, Karakiewicz PI, Montorsi F, Zerbib M, Gönen M, Shariat SF; UTUC Collaboration.

J Urol. 2013 Feb;189(2):468-73. doi: 10.1016/j.juro.2012.09.036. Epub 2012 Dec 14.

PMID:
23253960
12.

Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling.

Xylinas E, Cha EK, Sun M, Rink M, Trinh QD, Novara G, Green DA, Pycha A, Fradet Y, Daneshmand S, Svatek RS, Fritsche HM, Kassouf W, Scherr DS, Faison T, Crivelli JJ, Tagawa ST, Zerbib M, Karakiewicz PI, Shariat SF.

Br J Cancer. 2012 Nov 20;107(11):1826-32. doi: 10.1038/bjc.2012.464.

13.

Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.

Fajkovic H, Cha EK, Jeldres C, Robinson BD, Rink M, Xylinas E, Chromecki TF, Breinl E, Svatek RS, Donner G, Tagawa ST, Tilki D, Bastian PJ, Karakiewicz PI, Volkmer BG, Novara G, Joual A, Faison T, Sonpavde G, Daneshmand S, Lotan Y, Scherr DS, Shariat SF.

Eur Urol. 2013 Nov;64(5):837-45. doi: 10.1016/j.eururo.2012.07.026. Epub 2012 Jul 20.

PMID:
22877503
14.

Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy.

Rink M, Hansen J, Cha EK, Green DA, Babjuk M, Svatek RS, Xylinas E, Tagawa ST, Faison T, Novara G, Karakiewicz PI, Daneshmand S, Lotan Y, Kassouf W, Fritsche HM, Pycha A, Comploj E, Tilki D, Bastian PJ, Chun FK, Dahlem R, Scherr DS, Shariat SF.

BJU Int. 2013 Jan;111(1):74-84. doi: 10.1111/j.1464-410X.2012.11356.x. Epub 2012 Jul 19.

15.

A post preventive medicine program.

FAISON TG.

U S Armed Forces Med J. 1953 Jun;4(6):795-805. No abstract available.

PMID:
13049693

Supplemental Content

Loading ...
Support Center